1. Home
  2. MIRM vs MGY Comparison

MIRM vs MGY Comparison

Compare MIRM & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$64.32

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

HOLD

Current Price

$23.13

Market Cap

4.2B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
MGY
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.2B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
MIRM
MGY
Price
$64.32
$23.13
Analyst Decision
Strong Buy
Hold
Analyst Count
11
11
Target Price
$87.55
$25.20
AVG Volume (30 Days)
616.7K
1.9M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
2.66%
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
$471,794,000.00
$1,320,826,000.00
Revenue This Year
$53.78
$1.07
Revenue Next Year
$19.91
$2.71
P/E Ratio
N/A
$12.54
Revenue Growth
53.66
0.68
52 Week Low
$36.88
$19.09
52 Week High
$78.55
$26.84

Technical Indicators

Market Signals
Indicator
MIRM
MGY
Relative Strength Index (RSI) 35.49 51.55
Support Level $63.66 $22.50
Resistance Level $66.77 $23.83
Average True Range (ATR) 2.99 0.54
MACD -0.69 -0.01
Stochastic Oscillator 9.63 50.68

Price Performance

Historical Comparison
MIRM
MGY

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

Share on Social Networks: